Episode
The Injectable Breakthrough for Facial Changes After Medical Weight Loss — Dr. Rui Avelar
- Podcast
- The Dr. Randi Show
- Published
- Jan 8, 2026
- Duration seconds
- 1764
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-dr-randi-show-7023538/episodes/the-injectable-breakthrough-for-facial-changes-after-medical-weight-loss-dr-rui-avelar/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-dr-randi-show-7023538/the-injectable-breakthrough-for-facial-changes-after-medical-weight-loss-dr-rui-avelar.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode of The Dr. Randi Show , Dr. Randi Boyette sits down with Dr. Rui Avelar of Evolus, the company behind Evolysse, the first hyaluronic acid filler recognized for use in patients experiencing facial changes associated with weight loss medications. As these medications continue to change bodies and faces, this conversation explores what that shift means for aesthetic medicine and injectable innovation. This episode covers: • Evolysse and its entry into the U.S. injectable market • Hyaluronic acid fillers and the shift toward more natural outcomes • Evolysse as an entry point for patients new to injectables • Early patient and injector feedback from clinical use • Evolysse for use in patients experiencing medical right loss related facial changes • The growing intersection of weight loss medications and aesthetics This conversation explores how weight loss medications are reshaping facial aging, and why Evolysse marks a meaningful shift in addressing volume loss, skin changes, and natural-looking correction in aesthetic medicine.